Related Experiment Video
Updated: Feb 9, 2026
An Efficient Method for Selective Desalination of Radioactive Iodine Anions by Using Gold Nanoparticles-Embedded Membrane Filter
Published on: July 13, 2018
Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or
Essi Ryödi1,2, Saara Metso2,3, Heini Huhtala4
11 Heart Center Co., Tampere University Hospital , Tampere, Finland .
Insights
Hyperthyroidism increases cardiovascular disease (CVD) hospitalization risk, sustained post-treatment. Radioactive iodine (RAI) therapy for hyperthyroidism carries a higher CVD risk than thyroid surgery.
Area of Science:
- Endocrinology
- Cardiology
- Public Health
Background:
- Hyperthyroidism poses a persistent cardiovascular disease (CVD) risk even after achieving euthyroidism.
- The comparative impact of different hyperthyroid treatment modalities on long-term CVD risk is not well-established.
Purpose of the Study:
- To evaluate cardiovascular morbidity and mortality in hyperthyroid patients before and after treatment.
- To compare the effects of radioactive iodine (RAI) therapy versus thyroid surgery on subsequent CVD risk.
Main Methods:
- A comparative cohort study included 6148 hyperthyroid patients (RAI or thyroidectomy) and 18,432 controls.
- Analysis included pre-treatment CVD hospitalizations and post-treatment CVD hospitalization and mortality rates, adjusted for baseline CVD.
Main Results:
- Hyperthyroid patients had higher pre-treatment CVD hospitalizations (OR=1.61). Post-treatment, CVD hospitalizations remained elevated (HR=1.15), but CVD mortality showed no difference (HR=0.93).
- RAI treatment was associated with increased CVD hospitalizations (HR=1.17) and atrial fibrillation (HR=1.28) compared to thyroidectomy.
- RAI-treated patients also showed higher CVD mortality (HR=2.56), though hypothyroidism post-RAI was not linked to increased CVD morbidity.
Conclusions:
- Hyperthyroidism elevates CVD hospitalization risk, persisting for up to 20 years post-RAI or surgery.
- Radioactive iodine therapy for hyperthyroidism is associated with a greater CVD risk compared to thyroidectomy.
- Post-treatment hypothyroidism may be linked to improved cardiovascular outcomes.
Background:
Hyperthyroid patients remain at an increased risk of cardiovascular diseases (CVDs) after restoring euthyroidism. The impact of the different treatment modalities of hyperthyroidism on future CVD risk remains unclear. The aims of this study were to assess cardiovascular morbidity and mortality in hyperthyroidism before and after treatment, and to compare the effects of two different treatment modalities: radioactive iodine (RAI) and thyroid surgery.
Methods:
A comparative cohort study was conducted among 6148 hyperthyroid patients treated with either RAI or thyroidectomy and 18,432 age- and sex-matched controls. First, hospitalizations due to CVDs prior to the treatment were analyzed. Second, the hazard ratios (HR) for any new hospitalization and mortality due to CVDs after treatment were estimated among all the hyperthyroid patients compared to the age- and sex-matched controls and also in the RAI-treated patients compared to the thyroidectomy-treated patients. The results were adjusted for prevalent CVDs at the time of treatment.
Results:
Before treatment for hyperthyroidism, hospitalizations due to all CVDs were more common in the hyperthyroid patients compared to the controls (odds ratio = 1.61 [confidence interval (CI) 1.49-1.73]). During the post-treatment follow-up, hospitalizations due to CVDs remained more frequent among the patients (HR = 1.15 [CI 1.09-1.21]), but there was no difference in CVD mortality (HR = 0.93 [CI 0.84-1.03]). Compared to the patients treated with thyroidectomy, the RAI-treated patients had a higher risk of hospitalization due to all CVDs (HR = 1.17), atrial fibrillation (HR = 1.28), as well as a higher CVD mortality rate (HR = 2.56). Yet, treatment with RAI resulting in hypothyroidism was not associated with increased CVD morbidity compared to thyroidectomy.
Conclusions:
Hyperthyroidism increases the risk of CVD-related hospitalization, and the risk is sustained for up to two decades after treatment with RAI or surgery. Hyperthyroid patients treated with RAI remain at a higher CVD risk compared to patients treated with thyroidectomy. Hypothyroidism during follow-up, however, predicts better cardiovascular outcomes.
Related Concept Videos
03:18Radioactivity and Nuclear Equations
A nuclide of an element has a specific number of protons and...
02:48Radioactive Decay and Radiometric Dating
03:23Types of Radioactivity
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
01:14Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
01:13Electrophilic Aromatic Substitution: Fluorination and Iodination of Benzene
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...